Are Shares Of NovaBay Pharmaceuticals, Inc. (NBY) Really Worth?

NovaBay Pharmaceuticals, Inc. (NBY) has seen some recent movement in the marketplace and its common shares were last quoted at $1.3600 yesterday. Traders are starting to take notice of NBY as the common shares traded as high as $1.4800 and as low as $1.2800 in the prior market trading day.

NovaBay Pharmaceuticals, Inc. (NBY) average trading volume is 5.42M. However, in the prior market trading day NovaBay Pharmaceuticals, Inc. (NBY) traded 3,008,408 shares. The 1st support level on NBY is $1.26 and the 1st resistance level on NBY is $1.75. NBY fifty day moving average is $1.1966 and NBY 200 day moving average is $0.8627.

NovaBay Pharmaceuticals, Inc. (NBY) current performance has been shown by the recent movement in NBY common shares. NBY has performed 18.26% over the past month, NBY has performed 21.43% over the past 3 months and NBY has shown 15.25% over the past 12 months. NovaBay Pharmaceuticals, Inc. (NBY) has a 52 week range of $0.2400 to $1.9400. NovaBay Pharmaceuticals, Inc. (NBY) is trading 466.67% from its 52 week low and -29.90% from its 52 week high. NovaBay Pharmaceuticals, Inc. (NBY) is displaying a 5.76% short float displaying the sum short in the float.

NBY has 27.98M shares outstanding and 21.54M shares in the float. NovaBay Pharmaceuticals, Inc. (NBY) presently has a market cap of $43.23M and income of -7.90M. The EPS next quarter for NBY is -0.06 and projected EPS next year is 37.50%. The market cap of NovaBay Pharmaceuticals, Inc. (NBY) at $43.23M represents how many Traders own shares of NBY and is based off the last price ($1.3600) of NBY and the sum of shares outstanding (27.98M) with NovaBay Pharmaceuticals, Inc. (NBY).

NovaBay Pharmaceuticals, Inc. (NBY) has total cash (mrq) of 5.71M, total cash per share (mrq) of 0.2, total debt of NBY stands at 3.38M. NovaBay Pharmaceuticals, Inc. (NBY) running cash flow (ttm) is -5.57M, NBY leveraged free cash flow (ttm) is -2.1M.

NBY is trading 6.54% above (bullish) its SMA20, 24.87% above (bullish) its SMA50 and 74.79% above (bullish) its SMA200.

Related Articles

Zebra (NASDAQ: ZBRA) And XMReality Inks Partnership Agreement

Zebra Technologies Corporation (NASDAQ: ZBRA) and XMReality publicized that the two have signed an agreement to work together and collaborate on ideas that offer...

Elanco (NYSE: ELAN) Launch Public Offering Of Common Stock

Elanco Animal Health Inc. (NYSE: ELAN) shares that it is planning to commence the public offering of 54,500,000 shares of common stock. It will...

Jacobs (NYSE: J) Partners with PA Consulting

Jacobs Engineering Group, Inc. (NYSE: J), a famous construction company announced that it will be collaborating with PA Consulting. The firm has purchased an...

Get in Touch

19,000FansLike
35,222FollowersFollow
22,458FollowersFollow

Latest Posts

Zebra (NASDAQ: ZBRA) And XMReality Inks Partnership Agreement

Zebra Technologies Corporation (NASDAQ: ZBRA) and XMReality publicized that the two have signed an agreement to work together and collaborate on ideas that offer...

Elanco (NYSE: ELAN) Launch Public Offering Of Common Stock

Elanco Animal Health Inc. (NYSE: ELAN) shares that it is planning to commence the public offering of 54,500,000 shares of common stock. It will...

Jacobs (NYSE: J) Partners with PA Consulting

Jacobs Engineering Group, Inc. (NYSE: J), a famous construction company announced that it will be collaborating with PA Consulting. The firm has purchased an...

Fuwei (NASDAQ: FFHL) Plans To Sell Dornier Production Line

Fuwei Films (Holdings) Co., Ltd. (NASDAQ: FFHL) recently declared that it will be closing its Dornier line of production as early as possible. Fuwei...

PPG Industries (NYSE: PPG) Announces Accquisition Of Ennis-Flint

PPG Industries, Inc. (NYSE: PPG) is planning to buy Ennis-Flint in a deal valued at nearly $1.15 billion. The decision to acquire Ennis-Flint will...